Janssen Reminyl Benefit Seen Among Probable Vascular Dementia Patients

A study of Janssen's Reminyl (galantamine) showed benefits in patients with probable vascular dementia as well as patients with Alzheimer's disease with cerebrovascular components.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet